CCNE1 amplification	Ovarian Cancer	CCNE1 amplification	Ovarian Cancer	BLU-222 Sensitive: C2 – Inclusion Criteria BLU-222 Sensitive : C2	BLU-222 Sensitive: C2 – Inclusion Criteria BLU-222 Sensitive : C2
HR positive	HER2 Negative Breast Cancer	HR positive	HER2 Negative Breast Cancer	BLU-222 Sensitive: C3 – Early Trials BLU-222 Sensitive : C3	BLU-222 Sensitive: C3 – Early Trials BLU-222 Sensitive : C3
HR positive	HER2 Negative Breast Cancer	HR positive	HER2 Negative Breast Cancer	ribociclib + BLU-222 Sensitive: D – Preclinical ribociclib + BLU-222 Sensitive : D	ribociclib + BLU-222 Sensitive: D – Preclinical ribociclib + BLU-222 Sensitive : D
HR positive	HER2 Negative Breast Cancer	HR positive	HER2 Negative Breast Cancer	palbociclib + BLU-222 Sensitive: D – Preclinical palbociclib + BLU-222 Sensitive : D	palbociclib + BLU-222 Sensitive: D – Preclinical palbociclib + BLU-222 Sensitive : D

cirtociclib (BLU-222)

Associations
(4)